Fedratinib and its Impurities
Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. Reference standards of Fedratinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide
3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide
Catalogue No.:PA 06 2021002
CAS :
936091-39-3
Molecular Formula : C23H28N6O3S
Molecular Weight : 468.58